Evidence map›Paper›PMID 39318924›Full record

ArticleCureus2024

Prognostic Factors for Mortality in Patients With Autoimmune Diseases Complicated by Pneumocystis Pneumonia.

Kunika Shimizu, Nobuyuki Yajima, Ryo Yanai, Kuninobu Wakabayashi, Yusuke Miwa, Takaaki Matsuyama

Abstract read
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Mortality ofAnnals of medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Kunika ShimizuDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JPN.
Nobuyuki YajimaDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JPN.
Ryo YanaiDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JPN.
Kuninobu WakabayashiDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JPN.
Yusuke MiwaDivision of Rheumatology, Department of Medicine, Showa University School of Medicine, Tokyo, JPN.
Takaaki MatsuyamaDepartment of Legal Medicine, Showa University School of Medicine, Tokyo, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives Pneumocystis pneumonia (PCP) has a poor prognosis in patients with autoimmune diseases. Additionally, the mortality of PCP in autoimmune diseases is higher than that of human immunodeficiency virus-PCP. Therefore, this study aimed to assess the risk factors associated with mortality in patients with autoimmune diseases complicated with PCP. Methods We conducted a retrospective observational study involving 38 patients treated for PCP at Showa University School of Medicine from January 2010 to August 2014. Diagnoses were established based on clinical symptoms, imaging, and laboratory tests, including hypoxemia (partial pressure of oxygen (PaO2) < 70 mmHg), chest computed tomography findings, elevated (1,3)-β-D-glucan, and positive

Indexed as

autoimmune rheumatic diseasesimmunocompromised patientpneumocystis jiroveci pneumoniaprognostic risk factorsrheumatology & autoimmune diseases

Identifiers

PMID39318924
PMCPMC11421872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.